Abstract

BackgroundLaparoscopic sleeve gastrectomy (LSG) is a common surgical therapeutic option for obese patients, with debate about the value of routine histopathologic examination of LSG specimens. We assessed the following: prevalence of different histopathologic changes in LSG specimens, risk factors associated with premalignant and with frequent histopathologic changes, and whether routine histopathologic examination is warranted for LSG patients with nonsignificant clinical history.MethodsRetrospective review of records of all LSG patients operated upon at Hamad General Hospital, Qatar (February 2011–July 2014, n = 1555), was conducted. Risk factors (age, BMI, gender, and Helicobacter pylori) were assessed in relation to specific abnormal histopathologic changes.ResultsMean age and BMI of our sample were 35.5 years and 46.8, respectively. Females comprised 69.7% of the sample. Normal histopathologic specimens comprised 52% of the sample. The most common histopathologic changes were chronic inactive gastritis (33%), chronic active gastritis (6.8%), follicular gastritis (2.7%), and lymphoid aggregates (2.2%). We observed rare histopathology in 3.3% of the sample [e.g., intestinal metaplasia and gastrointestinal stromal tumor (GIST)]. Older age was associated with GIST and intestinal metaplasia (P = 0.001 for both). Females were associated with chronic active gastritis (P = 0.003). H. pylori infection was associated with follicular gastritis, lymphoid aggregates, GIST, intestinal metaplasia, and chronic active gastritis (P < 0.001 for each).ConclusionOlder age, H. pylori, and female gender are risk factors for several abnormal histopathologic changes. Histopathologic examination of LSG specimens might harbor significant findings; however, routine histopathologic examination of all LSG specimens, particularly in the absence of suggestive clinical symptoms, is questionable. The association between female gender and chronic active gastritis; and the association between H. pylori infection and GIST are both novel findings that have not been previously reported in the published literature.

Highlights

  • Obesity is a serious health problem worldwide where >1.9 billion adults are overweight, of which 600 million are obese [1]

  • Given the unequivocal opinion about the following: (a) whether abnormal gastric histopathologic changes are evident in high percentages of morbidly obese Laparoscopic sleeve gastrectomy (LSG) patients, (b) the risk factors associated with abnormal gastric histopathologic changes across LSG patients, and (c) the value of routine gastric histopathologic examination of LSG specimens, the current study examined 1555 LSG specimens at Hamad General Hospital in Doha, the largest hospital in the State of Qatar

  • The first most common histopathologic change (33%) was chronic inactive gastritis

Read more

Summary

Introduction

Obesity is a serious health problem worldwide where >1.9 billion adults are overweight, of which 600 million are obese [1]. Nonsurgical treatment of obesity (physical activity, diet/behavior modification, and pharmacotherapy) seems ineffective with severely obese patients (BMI > 40), or those with BMI 35–39.9 combined with comorbidities. Such patients can undergo either primarily restrictive (e.g., laparoscopic sleeve gastrectomy—LSG) or malabsorptive surgery (e.g., Roux-en-Y gastric bypass) [5]. Laparoscopic sleeve gastrectomy (LSG) is a common surgical therapeutic option for obese patients, with debate about the value of routine histopathologic examination of LSG specimens. We assessed the following: prevalence of different histopathologic changes in LSG specimens, risk factors associated with premalignant and with frequent histopathologic changes, and whether routine histopathologic examination is warranted for LSG patients with nonsignificant clinical history

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call